---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-23-001636"
form_type: "8-K"
ticker: null
cik: "0001602078"
company_name: "Nemaura Medical Inc."
filed_at: "2023-11-21T23:59:59+00:00"
generated_at: "2026-06-07T22:41:18.467035+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nemaura Medical secures $10M credit facility with Streeterville Capital, non-dilutive funding for growth

## Summary
- Line of credit facility for up to $10M from Streeterville Capital; maximum draw of $1M per month.
- Monitoring fee of 0.8333% per month on outstanding draws; 20% original issue discount added per draw.
- Facility secured by all assets of Nemaura, Dermal Diagnostics, and Trial Clinic.
- Management states structure minimizes dilution compared to equity sales, supporting commercialization.

## SEC filing metadata
- accession: 0001079973-23-001636
- form_type: 8-K
- cik: 0001602078
- company_name: Nemaura Medical Inc.
- filed_at: 2023-11-21T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.03, 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1602078/000107997323001636/0001079973-23-001636-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1602078/000107997323001636/nmra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-23-001636
- JSON: https://secwatch.observer/filing/0001079973-23-001636.json
- Plain text: https://secwatch.observer/filing/0001079973-23-001636.txt

## Key facts
- Debt Financings
  Nemaura Medical Inc. incurred credit facility of $10,000,000 with Streeterville Capital, LLC at 0.8333% per month maturing one year from the execution date of the LOC Agreement.
  - Instrument: credit facility
  - Principal: $10,000,000
  - Counterparty: Streeterville Capital, LLC
  - Rate: 0.8333% per month
  - Maturity: one year from the execution date of the LOC Agreement
  - Event: incurrence
  source text: credit (the “Line of Credit”) to the Borrower and to make advances to the Borrower from time to time, which amounts will not exceed at any time the aggregate principal amount of $10,000,000 (the “Maximum Loan Amount”), unless Streeterville agrees, in its sole discretion, to extend additional amounts of credit under the LOC Agreement. Subject to the terms and
  evidence_url: https://www.sec.gov/Archives/edgar/data/1602078/000107997323001636/0001079973-23-001636-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.